Venous Injection Compared To intraOsseous Injection During Resuscitation of Patients With Out-of-hospital Cardiac Arrest
VICTOR
1 other identifier
interventional
1,732
1 country
1
Brief Summary
Overall survival of patients after out-of-hospital cardiac arrest (\*OHCA\*) is less than 10% worldwide and in Taiwan. Interventions provided by the emergency medical system (\*EMS\*) before arrival at the hospital are of paramount importance to patient outcomes after OHCA. Among those interventions, the pros-and-cons of different vascular accesses, including intraosseous (\*IO\*) access or intravenous (\*IV\*) access, remained the issue of most under debate. The objective of this study is to determine the comparative effectiveness of IO access vs IV access in patients with OHCA by a randomized controlled trial (\*RCT\*) in Taipei EMS. To name in short, the investigators called it a "\*VICTOR\* trial" standing for "Venous Injection Compared To intraOsseous injection during Resuscitation of patients with out-of-hospital cardiac arrest".
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jul 2020
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 16, 2019
CompletedFirst Posted
Study publicly available on registry
October 22, 2019
CompletedStudy Start
First participant enrolled
July 6, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2023
CompletedOctober 23, 2023
October 1, 2023
3 years
October 16, 2019
October 19, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
the rate of survival to hospital discharge
OHCA patients with survival to hospital discharge
up to 1 month after the OHCA event
Secondary Outcomes (3)
the time and rate of return of spontaneous circulation (*ROSC*)
up to 1 week after the OHCA event
survival to admission
up to 1 week after the OHCA event
favorable neurologic survival staus
up to 1 month after the OHCA event
Other Outcomes (1)
subgroups analysis
through study completion, an average of half a year
Study Arms (2)
intra-osseous access, IO at the humeral site
EXPERIMENTALthe OHCA patients receiving IO at the humeral site by paramedics in the field
intravenous access; IV at the upper limb
ACTIVE COMPARATORthe OHCA patients receiving IV at the upper limb by paramedics in the field
Interventions
EZ-IO®: The Arrow® Intraosseous Vascular Access System from Teleflex IV-catheter: form local qualified manufactures
Eligibility Criteria
You may qualify if:
- Out-of-hospital cardiac arrest (OHCA) activated Taipei EMS ALS team (EMTP)
- Adult ≥ 20 years old
You may not qualify if:
- OHCA patients with signs of obvious death, e.g. rigor mortis
- Existing do-not-attempt-resuscitation order
- Patients with cardiac arrest en route to the hospital
- OHCA patients with successful vascular access before EMTP arrival
- OHCA patients with a canceled ambulance call or being transported to the hospital before EMTP arrival
- OHCA patients with known or suspected pregnancy
- OHCA patients with traumatic cause of cardiac arrest
- OHCA patients with known or suspected \< 20 years old, or \> 80 years old
- OHCA patients with contraindications to IO access or IV access
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- National Taiwan University Hospitallead
- Ministry of Science and Technology, Taiwancollaborator
- Teleflexcollaborator
Study Sites (1)
National Taiwan University Hospital
Taipei, 100, Taiwan
Related Publications (6)
Petitpas F, Guenezan J, Vendeuvre T, Scepi M, Oriot D, Mimoz O. Use of intra-osseous access in adults: a systematic review. Crit Care. 2016 Apr 14;20:102. doi: 10.1186/s13054-016-1277-6.
PMID: 27075364BACKGROUNDLink MS, Berkow LC, Kudenchuk PJ, Halperin HR, Hess EP, Moitra VK, Neumar RW, O'Neil BJ, Paxton JH, Silvers SM, White RD, Yannopoulos D, Donnino MW. Part 7: Adult Advanced Cardiovascular Life Support: 2015 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2015 Nov 3;132(18 Suppl 2):S444-64. doi: 10.1161/CIR.0000000000000261. No abstract available.
PMID: 26472995BACKGROUNDKawano T, Grunau B, Scheuermeyer FX, Gibo K, Fordyce CB, Lin S, Stenstrom R, Schlamp R, Jenneson S, Christenson J. Intraosseous Vascular Access Is Associated With Lower Survival and Neurologic Recovery Among Patients With Out-of-Hospital Cardiac Arrest. Ann Emerg Med. 2018 May;71(5):588-596. doi: 10.1016/j.annemergmed.2017.11.015. Epub 2018 Jan 6.
PMID: 29310869BACKGROUNDFeinstein BA, Stubbs BA, Rea T, Kudenchuk PJ. Intraosseous compared to intravenous drug resuscitation in out-of-hospital cardiac arrest. Resuscitation. 2017 Aug;117:91-96. doi: 10.1016/j.resuscitation.2017.06.014. Epub 2017 Jun 16.
PMID: 28629995BACKGROUNDMody P, Brown SP, Kudenchuk PJ, Chan PS, Khera R, Ayers C, Pandey A, Kern KB, de Lemos JA, Link MS, Idris AH. Intraosseous versus intravenous access in patients with out-of-hospital cardiac arrest: Insights from the resuscitation outcomes consortium continuous chest compression trial. Resuscitation. 2019 Jan;134:69-75. doi: 10.1016/j.resuscitation.2018.10.031. Epub 2018 Nov 1.
PMID: 30391366BACKGROUNDKo YC, Lin HY, Huang EP, Lee AF, Hsieh MJ, Yang CW, Lee BC, Wang YC, Yang WS, Chien YC, Sun JT, Ma MH, Chiang WC. Intraosseous versus intravenous vascular access in upper extremity among adults with out-of-hospital cardiac arrest: cluster randomised clinical trial (VICTOR trial). BMJ. 2024 Jul 23;386:e079878. doi: 10.1136/bmj-2024-079878.
PMID: 39043416DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Wen-Chu Chiang, PhD
Dept. of Emergency Medicine, NTUH
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- The intervention (IO vs IV route) on the patients with out-of-hospital cardiac arrest can not be masked.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 16, 2019
First Posted
October 22, 2019
Study Start
July 6, 2020
Primary Completion
June 30, 2023
Study Completion
June 30, 2023
Last Updated
October 23, 2023
Record last verified: 2023-10
Data Sharing
- IPD Sharing
- Will not share